This inventor holds 2 USPTO granted patents. Top assignee: Astrazeneca Ab. Active years: 2002-2003.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2002-2003
Title: Martin Nylöf: Innovator in Substituted Chroman Derivatives
Introduction
Martin Nylöf is a notable inventor based in Södertälje, Sweden. He has made significant contributions to the field of chemistry, particularly in the development of substituted chroman derivatives. With a total of 2 patents to his name, Nylöf continues to push the boundaries of innovation in his area of expertise.
Latest Patents
Nylöf's latest patents focus on substituted chroman derivatives, showcasing his commitment to advancing chemical research. These innovations have the potential to impact various applications in pharmaceuticals and beyond.
Career Highlights
Currently, Martin Nylöf is employed at AstraZeneca AB, a leading global biopharmaceutical company. His work at AstraZeneca has allowed him to collaborate with some of the brightest minds in the industry, further enhancing his contributions to scientific research.
Collaborations
Throughout his career, Nylöf has worked alongside esteemed colleagues such as Stefan Berg and Svante Bertil Ross. These collaborations have fostered a rich environment for innovation and have led to the successful development of new chemical compounds.
Conclusion
Martin Nylöf is a dedicated inventor whose work in substituted chroman derivatives exemplifies the spirit of innovation. His contributions to AstraZeneca and the field of chemistry continue to inspire future advancements.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile